British charity Mind launches new green agenda for mental health, based on new research findings i.e. 71 per cent report depression decrease after green walk, 22 per cent report depression increase after urban walk.
Nearly a quarter of a million Americans each year may be hospitalized with bleeding complications caused by needlessly taking a daily dose of an adult-sized aspirin rather than a baby aspirin to prevent a heart attack or stroke.
No one is at zero risk for stroke, which explains why it is vital to know the signs and understand how to decrease the chance of experiencing a stroke.
A combination of three different drugs that block the HER-2 receptor, a critical cellular growth signal for some breast cancers, eradicated aggressive breast tumors in mice and could point the way toward developing better treatments in patients, said researchers from the Breast Center at Baylor College of Medicine in a report that appears in the Journal of the National Cancer Institute.
A report released by the Australian Institute of Health and Welfare suggests that some asthma medications are not being used in the optimal way by most people.
Boehringer Ingelheim GmbH announced that it has initiated and begun enrollment of patients in the ArTEN trial, which will compare the efficacy and safety of Viramune? (nevirapine), a non-nucleoside reverse transcriptase inhibitor (NNRTI), dosed once daily (QD) or twice daily (BID), versus atazanavir/ritonavir, a once-daily dosed protease inhibitor (PI).
Roche announced that the U.S. Food & Drug Administration (FDA) has approved its new HIV-1 test for diagnostic use in the United States. The highly accurate Cobas AmpliPrep/Cobas TaqMan HIV-1 Test is the first fully automated HIV-1 diagnostic tool using real-time PCR technology in the US.
Axcan Pharma Inc. (TSX:AXP)(NASDAQ:AXCA) announced the launch of PYLERA in the United States. PYLERA is a patented 3-in-1 capsule triple therapy for the eradication of Helicobacter pylori, which is a bacterium recognized as being the main cause of gastric and duodenal ulcers.
The results of the 2006 National Sentinel Audit for Stroke show that patients are spending more of their time on stroke units, but there are still unacceptable waits for brain scans and starting treatment.
Boston Scientific Corporation (NYSE: BSX) commented on data released on May 9th at the American Association for Thoracic Surgery (AATS) conference in Washington, D.C. Dudley A. Hudspeth, M.D., of Desert Cardiothoracic Surgeons in Mesa, Arizona, reported positive results from his single-center clinical investigation of 79 patients treated with the FLEX 10? and FLEX 10? XE Microwave Ablation Probes.